Hanmi Pharm
Hanmi Pharm Co Ltd is a South Korean pharmaceutical manufacturing company headquartered in Seoul, South Korea. The firm develops, manufactures, and markets prescription pharmaceuticals, over-the-counter medicines, and active pharmaceutical ingredients. Its product lineup focuses on cardiovascular, metabolic, oncology, and central nervous system therapeutic areas. Revenue is derived from the sales of branded prescription drugs, generic medicines, and technology licensing agreements with global biopharmaceutical companies. The firm serves hospitals, pharmacies, and healthcare providers domestically and internationally. Hanmi Pharm Co Ltd is listed on the Korea Exchange.
6 of the funds FundTelligence covers report a position in Hanmi Pharm.
- Legal name
- Hanmi Pharm Co Ltd
- Sector
- Health Care
- Country
- South Korea
- Funds holding it
- 6
Funds holding Hanmi Pharm
- JPM Korea Equity Fund — JPM · 0.85 % (full portfolio disclosed, June 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.05 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.02 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, September 2026)
- Storebrand Emerging Markets — Storebrand · 0.01 % (full portfolio disclosed, October 2026)
- Storebrand Global All Countries — Storebrand · 0.0 % (full portfolio disclosed, October 2026)